期刊文献+

参芪二至汤加减对气阴两虚型IgA肾病患者尿IL-17、IL-6水平的影响 被引量:6

Effect of Shenqi Erzhi Decoction(参芪二至汤) on Urinary IL-17 and IL-6 in Patients with IgA Nephropathy of Qi-Yin Deficiency Syndrome
下载PDF
导出
摘要 目的:观察参芪二至汤加减治疗气阴两虚型Ig A肾病(Ig AN)的临床疗效及对患者尿IL-17、IL-6水平的影响。方法:将60例气阴两虚型Ig AN患者随机分为治疗组(参芪二至汤加减+缬沙坦组)和对照组(缬沙坦组)各30例,观察治疗前后的24 h尿蛋白定量、血肌酐(SCr)、尿红细胞计数、尿IL-17、尿IL-6水平和中医证候积分变化。结果:对照组治疗2个月后尿蛋白定量、尿IL-17、IL-6定量、SCr和中医证候积分均下降,尿红细胞计数减少,差异均有统计学意义(P<0.05)。治疗组治疗1个月、2个月后尿蛋白定量、尿IL-17、IL-6定量、SCr和中医证候积分均下降,尿红细胞计数减少,差异均有统计学意义(P<0.05)。治疗后1个月、2个月两组比较,治疗组尿蛋白定量,尿红细胞计数、中医证候积分、尿IL-17、IL-6水平均低于对照组,差异均有统计学意义(P<0.05或P<0.01)。两组疗效比较,治疗组优于对照组,差异有统计学意义(P<0.01)。结论:参芪二至汤加减治疗气阴两虚证Ig A肾病疗效显著,可减少24 h尿蛋白定量、尿红细胞,降低SCr、尿IL-17、IL-6水平,从而更有效改善该型Ig AN患者临床症状。 Objective: To observe the clinical effect of Shenqi Erzhi Decoction on Ig A nephropath(Ig AN)with Qi-Yin Deficiency syndrome and its effect on the levels of urinary IL-17 and IL-6 in patients. Methods:A total of 60 cases of Ig AN patients with Qi-Yin Deficiency syndrome were randomly divided into treatment group(Shenqi Erzhi Decoction and valsartan group) and control group(valsartan group), 30 cases for each. The change of 24 h urine protein, serum creatinine(SCr), urine red blood cell count, level of urine IL-17, urine IL-6 and TCM syndrome score were observed before and after treatment. Results: The quantitation of urine protein,urine IL-17, urine IL-6, SCr, the socre of TCM syndrome, and the urinary red blood cell count of the control group were decreased after 2 month treatment, the difference is statistically significant(P〈0.05). The quantitation of urine protein, urine IL-17, urine IL-6, SCr, the socre of TCM syndrome, and the urinary red blood cell count of the treatment group were decreased after 1 and 2 months treatment, the difference is statistically significant(P〈0.05).The quantitation of urine protein, urine IL-17, urine IL-6, SCr, the socre of TCM syndrome, and the urinary red blood cell count of the control group was significant lower than the treatment group after 1 and2 months treatment, the difference is statistically significant(P〈0.05 or P〈0.01). After treatment, the treatment group showed better efficacy than the control group(P〈0.05). Conclusion: The curative effect of Shenqi Erzhi Decoction in the treatment of Ig A Nephropathy of Qi-Yin Deficiency syndrome is significant. It can effectively decrease the 24 h urine protein, urine red blood cells, SCr, urinary IL-17 and IL-6 levels, and thus more effective in improving the clinical symptoms of Ig AN patients.
作者 李亦聪 李轶群 石咏军 钟启腾 陈翠萍 陈学文 LI Yi-cong;LI Yi-qun;SHI Yong-jun;ZHONG Qi-teng;CHEN Cui-ping;CHEN Xue-wen(Huizhou Municipal Central Hospital, Huizhou Guangdong 516001, China)
出处 《中医药导报》 2018年第11期78-80,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 广东省中医药局"建设中医药强省"科研课题(20152085)
关键词 IGA肾病 气阴两虚证 参芪二至汤 白介素-17 白介素-6 IgAN Qi-Yin Deficiency syndrome Shenqi Erzhi Decoction IL-17 IL-6
  • 相关文献

参考文献3

二级参考文献31

  • 1陈香美,陈以平,李平,陈建,谌贻璞,周柱亮,陈威,赵宗江,危成筠,魏日胞,邓跃毅,李建军,杜婧,周瑾,何亚妮.1016例IgA肾病患者中医证候的多中心流行病学调查及相关因素分析[J].中国中西医结合杂志,2006,26(3):197-201. 被引量:230
  • 2陈香美,陈建,陈以平,周柱亮,何亚妮,李平,魏日胞,邓跃毅,赵宗江,危成筠,李建军,杜婧.肾华片治疗IgA肾病(气阴两虚证)多中心随机对照临床观察[J].中国中西医结合杂志,2007,27(2):101-105. 被引量:58
  • 3聂莉芳.IgA肾病的诊断、辨证分型和疗效评定(试行方案)[J].上海中医药杂志,2007,41(5):9-10. 被引量:108
  • 4Weaver C, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol, 2007,25 : 821-852.
  • 5Wang Y, Ito S, Chino Y, et al. Laser mierodissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol, 2010,159: 1 -10.
  • 6Loong CC, Hsieh HG, Lui WY, et al. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol,2002,197:322-332.
  • 7Tomizawa K, Nagao T, Kusunoki R, et al. Reduction of MPO- ANCA epitopes in SCG/Kj mice by15-deoxyspergualin treatment restricted by IgG2b associated with crescentic glomerulonephritis. Rheumatology, 2010,49 : 1245-1256.
  • 8Matsumoto K, Kanmatsuse K. Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy. Scand J Urol Nephrol, 2003, 37: 164-171.
  • 9Katafuchi R,Kiyshi Y,Oh Y. Glomerular score as a prognosticator in IgA nephropathy: Its useIulness and limitation. Ctin Nephrol, 1998,49:1-8.
  • 10Guglani L,Khader SA. Thl7 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS, 2010,5 : 120-127.

共引文献394

同被引文献107

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部